Analyst: Cancer Drugs Push Investors Into Pharma

Is the biotechnology sector’s high–flying ways coming to an end? Perhaps. Down 1.8% on Monday amid sizable sell offs by several well-watched companies, the Nasdaq Biotechnology Index has fallen 5% since hitting a multi-year high last month. But with the AMEX Pharmaceutical Index climbing 1% today, some investment pros said shareholders were exiting biotechnology stocks [...]